CPT code 0100T denotes the surgical implantation of a retinal prosthesis (artificial retina) to restore basic light perception in patients with severe retinal degeneration. The procedure places a silicone-and-platinum device and an electrode array in the epiretinal space to transmit external images and reestablish the distinction between presence and absence of light. Nationally, this code represents a specialized, high-cost interventional approach for select patients with conditions such as retinitis pigmentosa and certain hereditary retinal disorders and forms of age-related macular degeneration.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting, and coverage-relevant considerations for major national payers. The publication summarizes expected use cases for 0100T, highlights typical sites of service (hospital operating rooms and ambulatory surgical centers), and provides an outline of what to expect regarding coding classification and claim submission elements.

This resource is intended for billing managers, clinical coders, and policy analysts seeking a national view of the clinical purpose and administrative framing of CPT code 0100T. Data not available in the input will be noted where applicable.